![Tom Robertshaw](https://profiles-cardiff.imgix.net/attachments/2953?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Mr Tom Robertshaw
Teams and roles for Tom Robertshaw
Publication
2022
- James, E. et al. 2022. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37 (3) e2835. (10.1002/hup.2835)
2020
- James, E. et al., 2020. Psilocybin occasioned mystical‐type experiences. Human Psychopharmacology: Clinical and Experimental 35 (5) e2742. (10.1002/hup.2742)
2019
- James, E. et al. 2019. Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs.. Drug Science, Policy and Law 5 (10.1177/2050324519876123)
- James, E. , Robertshaw, T. L. and Westwell, A. D. 2019. Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances. Future Medicinal Chemistry 11 (3)(10.4155/fmc-2018-0447)
2018
- James, E. et al. 2018. Pharmacies as potential providers of harm reduction services: A preliminary online survey. Drug Science, Policy and Law 4 , pp.1-14. (10.1177/2050324518767441)
Articles
- James, E. et al. 2022. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37 (3) e2835. (10.1002/hup.2835)
- James, E. et al. 2019. Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs.. Drug Science, Policy and Law 5 (10.1177/2050324519876123)
- James, E. et al. 2018. Pharmacies as potential providers of harm reduction services: A preliminary online survey. Drug Science, Policy and Law 4 , pp.1-14. (10.1177/2050324518767441)
- James, E. et al., 2020. Psilocybin occasioned mystical‐type experiences. Human Psychopharmacology: Clinical and Experimental 35 (5) e2742. (10.1002/hup.2742)
- James, E. , Robertshaw, T. L. and Westwell, A. D. 2019. Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances. Future Medicinal Chemistry 11 (3)(10.4155/fmc-2018-0447)